Outlook Therapeutics OTLK
NASDAQ OTLK
$0.56 +0.04 (+7.77%)
As of: Oct 21, 2026 · 3:50 PM EDT

Outlook Therapeutics (OTLK) Receivables - Net (2015 - 2026)

Updated

Outlook Therapeutics (OTLK) recorded Receivables - Net of $1.64 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 6.1% from $1.75 million a year earlier and down 39.5% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Receivables - Net (2015 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics reported Receivables - Net of $1.49 million.

  • Quarterly Receivables - Net has ranged from $114,609 in fiscal Q1 2026 to $2.72 million in fiscal Q2 2026 over the past five years.
  • Per Business Quant, the preceding three fiscal quarters came in at $2.72 million (Q2 2026), $114,609 (Q1 2026) and $1.49 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,138.83 Bn 1,107.41 Bn 19.71 Bn
2 Johnson & Johnson 618.88 Bn 537.41 Bn 17.26 Bn
3 AbbVie 502.93 Bn 476.04 Bn 12.70 Bn
4 Merck 369.61 Bn 323.99 Bn 12.21 Bn
5 Novartis Ag 298.70 Bn 262.69 Bn 11.24 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn
7 Amgen 237.59 Bn 192.99 Bn 7.24 Bn
8 Gilead Sciences 191.60 Bn 165.79 Bn 6.22 Bn
9 Pfizer 170.23 Bn 116.88 Bn 10.94 Bn
10 Outlook Therapeutics 76.86 Mn 41.11 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.64 Mn
Mar 31, 2026 2.72 Mn
Dec 31, 2025 114,609.00
Sep 30, 2025 1.49 Mn
Jun 30, 2025 1.75 Mn
Jun 30, 2016 3,670.00
Mar 31, 2016 504,857.00
Sep 30, 2015 20,000.00
API Access

Outlook Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=OTLK&period=max&api_key=YOUR_API_KEY